Answer
Concomitant leniolisib phosphate (Joenja) and clarithromycin should be avoided because clarithromycin inhibits CYP3A4, potentially increasing exposure to leniolisib, a CYP3A4 substrate.
Sources for this answer
- Joenja 70 mg Film-coated tabletsPharming Technologies B.V. · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked